61 related articles for article (PubMed ID: 3146147)
1. Norepinephrine and DDAVP induced rise in tissue plasminogen activator.
Grant PJ; Wiles PG; Davies JA; Prentice CR
Thromb Haemost; 1988 Oct; 60(2):342. PubMed ID: 3146147
[No Abstract] [Full Text] [Related]
2. The initial release of t-PA induced by dDAVP is more important with low molecular weight heparin than with unfractionated heparin.
Schved JF; Gris JC; Sarlat C
Thromb Haemost; 1991 Jan; 65(1):109. PubMed ID: 1850874
[No Abstract] [Full Text] [Related]
3. Induction of uPA release in human peripheral blood lymphocytes by [deamino-Cysl,D-Arg8]-vasopressin (dDAVP).
Yamaguchi Y; Yamada K; Suzuki T; Wu YP; Kita K; Takahashi S; Ichinose M; Suzuki N
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E970-6. PubMed ID: 15198931
[TBL] [Abstract][Full Text] [Related]
4. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
[TBL] [Abstract][Full Text] [Related]
5. DDAVP releases tPA in correlation with a fall in platelet serotonin in uraemic patients.
Malyszko J; Malyszko JS; Azzadin A; Mysliwiec M; Buczko W
Thromb Res; 1992 Nov; 68(3):303-8. PubMed ID: 1471076
[No Abstract] [Full Text] [Related]
6. The release of factor VIII and tissue plasminogen activator can not be blocked by specific antagonists to vasopressin.
Vilhardt H; Barth T
J Recept Res; 1991; 11(1-4):239-45. PubMed ID: 1909360
[TBL] [Abstract][Full Text] [Related]
7. Unchanged plasma concentrations of endothelin-1 in healthy men during short-term infusions of AMP, dDAVP and of norepinephrine.
Wagner OF; Nowotny P; Vierhapper H
Horm Metab Res; 1991 Apr; 23(4):191-2. PubMed ID: 1831436
[No Abstract] [Full Text] [Related]
8. [Experimental studies of the liberation of plasminogen activator by DDAVP].
Jablonowski C; Klöcking HP; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
[TBL] [Abstract][Full Text] [Related]
9. Normal response to DDAVP in patients with plathology of the hypothalamoneurohypophyseal axis.
Vincente V; Corrales J; Miralles J; Alberca I
Thromb Res; 1987 Mar; 45(5):695-7. PubMed ID: 3109066
[No Abstract] [Full Text] [Related]
10. Thrombolytic therapy causes an increase in vascular permeability that is reversed by 1-deamino-8-D-vasopressin.
Rudd MA; Johnstone MT; Rabbani LE; George D; Ware JA; Loscalzo J
Circulation; 1991 Dec; 84(6):2568-73. PubMed ID: 1835680
[TBL] [Abstract][Full Text] [Related]
11. V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
Bernat A; Hoffmann P; Dumas A; Serradeil-le Gal C; Raufaste D; Herbert JM
J Pharmacol Exp Ther; 1997 Aug; 282(2):597-602. PubMed ID: 9262320
[TBL] [Abstract][Full Text] [Related]
12. DDAVP stimulates prostacyclin production.
Belch JJ; Small M; McKenzie F; Hill PA; Lowe GD; McIntyre DE; Forbes CD; Prentice CR
Thromb Haemost; 1982 Apr; 47(2):122-3. PubMed ID: 6808693
[TBL] [Abstract][Full Text] [Related]
13. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S
Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599
[TBL] [Abstract][Full Text] [Related]
14. Factor VIII and tissue plasminogen activator in monkeys after administration of DDAVP analogues.
Vilhardt H; Barth T
Thromb Res; 1992 Dec; 68(6):501-4. PubMed ID: 1341062
[No Abstract] [Full Text] [Related]
15. The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities.
Moffat EH; Giddings JC; Bloom AL
Br J Haematol; 1984 Aug; 57(4):651-62. PubMed ID: 6430337
[TBL] [Abstract][Full Text] [Related]
16. Reduced effect of exercise and DDAVP on factor VIII-von Willebrand Factor and plasminogen activator after sequential application of both the stimuli.
Vicente V; Alberca I; Mannucci PM
Thromb Haemost; 1984 Feb; 51(1):129-30. PubMed ID: 6426078
[No Abstract] [Full Text] [Related]
17. The inability of propranolol and aspirin to inhibit the response of fibrinolytic activity and factor VIII-antigen to infusion of DDAVP.
Brommer EJ; Derkx FH; Barrett-Bergshoeff MM; Schalekamp MA
Thromb Haemost; 1984 Feb; 51(1):42-4. PubMed ID: 6426080
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator enhancing activity of vasopressin analogues in monkeys: structure-activity study.
Vilhardt H; Barth T
J Recept Res; 1993; 13(1-4):305-11. PubMed ID: 8450495
[TBL] [Abstract][Full Text] [Related]
19. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease.
Wieczorek I; Ludlam CA; MacGregor IR
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):329-34. PubMed ID: 8075304
[TBL] [Abstract][Full Text] [Related]
20. Impaired capacity for endogenous fibrinolysis in essential hypertension.
Hrafnkelsdóttir T; Wall U; Jern C; Jern S
Lancet; 1998 Nov; 352(9140):1597-8. PubMed ID: 9843110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
